Edward G. Hughes
Papers
2
Total Citations
35
H-Index
2
About
Edward G. Hughes is a translational researcher whose work bridges genomics and ophthalmology, with a focus on clinical implementation and therapeutic innovation. His key research areas include next-generation sequencing (NGS) for precision oncology and stereotactic radiotherapy for retinal disease. Hughes made a major contribution to cancer genomics by leading the validation and implementation of a somatic-only tumor exome for routine clinical use, addressing the critical challenge of standardizing genomic testing across institutions with diverse resources. This work, published in 2024, has already garnered 23 citations, reflecting its immediate impact on clinical workflows. In ophthalmology, Hughes was instrumental in the pivotal STAR trial, a randomized, double-masked, sham-controlled study demonstrating that stereotactic radiotherapy can mitigate pathogenic processes in neovascular age-related macular degeneration (nAMD), offering a potential alternative to repeated anti-VEGF injections. This landmark trial, with 12 citations, represents a significant advance in treating a leading cause of blindness. Hughes’s ability to drive both genomic tool development and novel therapeutic strategies underscores his versatility and impact, making his work essential reading for researchers in precision medicine and retinal therapeutics.
Research Focus
Key Achievements
Top Papers
- 1
- 2